Chinachem Leighton Plaza
9th Floor 29 Leighton Road
Causeway Bay
Hong Kong
852 2155 0823
https://www.regencellbioscience.com
Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno: 12
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Yat-Gai Au | Founder, Chairman & CEO | N/D | N/D | 1973 |
Ms. Michelle Chan | Financial Controller | N/D | N/D | N/D |
Mr. Wai Hong Chung | COO & Chief Strategy Officer | 245,64k | N/D | 1977 |
Ms. Antonia Assang | Senior Vice President of Project Management | N/D | N/D | N/D |
Mr. Yat-Pui Au | Chief Business Officer | N/D | N/D | 1974 |
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder, as well as infectious diseases. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
L'ISS Governance QualityScore di Regencell Bioscience Holdings Limited al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.